Renova Therapeutics' Series C Round

Renova Therapeutics raised a round of funding on November 18, 2014.

Renova Therapeutics is a San Diego-based biopharmaceutical company and an industry leader in gene therapy, pursuing the development of treatments for congestive heart failure (CHF) and other chronic d…

Articles about Renova Therapeutics' Series C Round: